نتایج جستجو برای: anti rejection therapy

تعداد نتایج: 996561  

2005
Makoto Yamada Tsuneo Kato Masaki Naito Hisashi Kawai

This paper proposes an efficient anti-keyword derivation method to improve the rejection performance of keyword spotting. In this method, each anti-keyword is derived from the large vocabulary lexicon considering acoustic similarity to keywords, making use of the confusion matrix. Experimental results show that a 3 % improvement of the rejection rate is obtained compared to conventional methods...

Journal: :The Journal of Experimental Medicine 1991
M Mieno R Suto Y Obata H Udono T Takahashi H Shiku E Nakayama

The generation of an in vitro major histocompatibility complex class I specific response of CD4-CD8- T cell receptor (TCR) alpha beta cytotoxic T lymphocytes (CTL) and their allogeneic tumor rejection were investigated. Inocula of BALBRL male 1 were rejected in C57BL/6 (B6) mice treated with minimum essential medium (MEM) (control), anti-L3T4 (CD4) monoclonal antibody (mAb) or anti-Lyt-2.2 (CD8...

Journal: :Diabetes care 2006
Volkert A L Huurman Jayant S Kalpoe Pieter van de Linde Norbert Vaessen Jan Ringers Aloys C M Kroes Bart O Roep Johan W De Fijter

OBJECTIVE Simultaneous pancreas-kidney (SPK) transplantation in type 1 diabetic patients requires immunotherapy against allo- and autoreactive T-cells. Cytomegalovirus (CMV) infection is a major cause for morbidity after transplantation and is possibly related to recurrent autoimmunity. In this study, we assessed the pattern of CMV viremia in SPK transplant recipients receiving either antithymo...

Journal: :International immunology 1998
G Terres R L Coffman

The effect of systemic administration of anti-inflammatory cytokines (IL-4 and IL-10) on the development and maintenance of an anti-tumor rejection response in vivo was studied by following the growth patterns of P815.B7 tumors on B6D2F1 [(C57BI/6 x DBA/2)F1] mice. The anti-P815.B7 rejection response was found to be T cell dependent, involving both CD4 and CD8 cells. IL-4 treatment resulted in ...

Background and purpose: Kidney transplant is a major form of renal replacement therapy in many patients at advanced stages of the disease. Transplant rejection is a major complication following kidney transplant that could be reversible or irreversible. The present study was done to investigate the incidence of irreversible kidney transplant rejection. Materials and methods: A retrospective co...

Journal: :Acta medica Okayama 1993
S Maruyama Y Sano H Date N Shimizu S Teramoto

Early diagnosis of rejection and timely immunosuppression are absolutely important in clinical lung transplantation. We studied surface markers of peripheral blood lymphocytes (PBL), graft infiltrating lymphocytes (GIF) and bronchoalveolar lavage fluid (BALF) in a rat using flow cytometric monitoring to diagnose rejection. Left lung transplantation was performed on Brown Norway (BN) rats and Le...

Journal: :مجله دانشکده پزشکی دانشگاه علوم پزشکی تهران 0
ماهرو میراحمدیان m mir ahmadian بهروز نیک بین b nikbin سید عبدالرحیم رضائی a rezai

for monitoring of renal transplant function, serum b2m was evaluated in 23 recipients. according to clinical diagnosis the patients were in four groups: 1) successful renal transplant the mean concentration of sb2m pretransplantation was 73.1±26.1 mg/l but decreased to nearly normal level (4.43±1.17 mg/l) within 24-48h and then reached to 3.1 mg/l duting 20 days after transplantation. 2) renal ...

2016
Angus W. Thomson Alan F. Zahorchak Mohamed B. Ezzelarab Lisa H. Butterfield Fadi G. Lakkis Diana M. Metes

Dendritic cells (DC) are rare, professional antigen-presenting cells with ability to induce or regulate alloimmune responses. Regulatory DC (DCreg) with potential to down-modulate acute and chronic inflammatory conditions that occur in organ transplantation can be generated in vitro under a variety of conditions. Here, we provide a rationale for evaluation of DCreg therapy in clinical organ tra...

Journal: :Journal of immunology 2013
Tyce J Kearl Weiqing Jing Jill A Gershan Bryon D Johnson

Early phase clinical trials targeting the programmed death receptor-1/ligand-1 (PD-1/PD-L1) pathway to overcome tumor-mediated immunosuppression have reported promising results for a variety of cancers. This pathway appears to play an important role in the failure of immune reactivity to malignant plasma cells in multiple myeloma patients, as the tumor cells express relatively high levels of PD...

Journal: :Journal of immunology 2002
Yuan Zhai Lingzhong Meng Feng Gao Ronald W Busuttil Jerzy W Kupiec-Weglinski

We have shown that CD8(+) CTLs are the key mediators of accelerated rejection, and that CD8(+) T cells represent the prime targets of CD154 blockade in sensitized mouse recipients of cardiac allografts. However, the current protocols require CD154 blockade at the time of sensitization, whereas delayed treatment fails to affect graft rejection in sensitized recipients. To elucidate the mechanism...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید